BioCentury | Feb 26, 2021
Management Tracks

Ziopharm CEO stepping down; plus moves at ChemoCentryx, ReForm, Monte Rosa and Enterin

...at various healthcare consultancies and investment banks including KLW Advisors, Ondra Partners, HSBC Securities, SG Cowen...
BioCentury | Feb 19, 2021
Finance

Evox eyes clinic for internal pipeline with £69.2M series C round

...the company’s 2016 A round, also participated in the series C alongside OrbiMed, Invus, GV, Cowen...
BioCentury | Feb 19, 2021
Product Development

First-time CEOs must stop doing what made them successful: Guest Commentary

...Biotech Analyst, and Brendan Smith, Associate, Equity Research, Cowen...
...of the more surprising takeaways of research Cowen...
...according to the industry leaders interviewed by Cowen...
BioCentury | Feb 11, 2021
Product Development

Feb. 10 Quick Takes: Softly goes PacBio; plus PGDx, Nuvation Bio, Gamida, Portal Innovations

...biopsy company Personal Genome Diagnostics Inc. raised $103 million in a series C round led by Cowen...
BioCentury | Feb 3, 2021
Finance

argenx raises $1B as it readies to challenge Soliris

...million shares at €265.69 in a private placement in Europe. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen...
BioCentury | Jan 15, 2021
Product Development

Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection

...Ventures, AV8 Ventures and Windham Venture Partners, and new investors including Foresite Capital, Northpond Ventures, Cowen...
BioCentury | Jan 12, 2021
Deals

bluebird’s split could yield two attractive M&A targets

...bluebird had $1.3 billion in cash. Terms of the spinout have not been disclosed, but Cowen’s...
BioCentury | Jan 6, 2021
Product Development

Propelled by Ionis deal, Aro raises $88M series A to advance targeted oligo pipeline

...Biotherapeutics Co. raised an $88 million series A round Tuesday led by Northpond Ventures and Cowen...
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...Capital, Invus, Farallon Capital Management, BVF Partners, Cowen...
BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...a University of Toronto team including Leah Cowen...
Items per page:
1 - 10 of 3136
BioCentury | Feb 26, 2021
Management Tracks

Ziopharm CEO stepping down; plus moves at ChemoCentryx, ReForm, Monte Rosa and Enterin

...at various healthcare consultancies and investment banks including KLW Advisors, Ondra Partners, HSBC Securities, SG Cowen...
BioCentury | Feb 19, 2021
Finance

Evox eyes clinic for internal pipeline with £69.2M series C round

...the company’s 2016 A round, also participated in the series C alongside OrbiMed, Invus, GV, Cowen...
BioCentury | Feb 19, 2021
Product Development

First-time CEOs must stop doing what made them successful: Guest Commentary

...Biotech Analyst, and Brendan Smith, Associate, Equity Research, Cowen...
...of the more surprising takeaways of research Cowen...
...according to the industry leaders interviewed by Cowen...
BioCentury | Feb 11, 2021
Product Development

Feb. 10 Quick Takes: Softly goes PacBio; plus PGDx, Nuvation Bio, Gamida, Portal Innovations

...biopsy company Personal Genome Diagnostics Inc. raised $103 million in a series C round led by Cowen...
BioCentury | Feb 3, 2021
Finance

argenx raises $1B as it readies to challenge Soliris

...million shares at €265.69 in a private placement in Europe. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen...
BioCentury | Jan 15, 2021
Product Development

Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection

...Ventures, AV8 Ventures and Windham Venture Partners, and new investors including Foresite Capital, Northpond Ventures, Cowen...
BioCentury | Jan 12, 2021
Deals

bluebird’s split could yield two attractive M&A targets

...bluebird had $1.3 billion in cash. Terms of the spinout have not been disclosed, but Cowen’s...
BioCentury | Jan 6, 2021
Product Development

Propelled by Ionis deal, Aro raises $88M series A to advance targeted oligo pipeline

...Biotherapeutics Co. raised an $88 million series A round Tuesday led by Northpond Ventures and Cowen...
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...Capital, Invus, Farallon Capital Management, BVF Partners, Cowen...
BioCentury | Jan 1, 2021
Targets & Mechanisms

A snapshot of target innovation in 2020

...a University of Toronto team including Leah Cowen...
Items per page:
1 - 10 of 3136